Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients

In recent years, significant progress has been made in new therapeutic approaches to breast cancer, particularly in patients with HER2-positive and HER2-negative/hormone receptor-positive (HR+) breast cancer. In the case of HER2-positive tumours, these approaches have included, in particular, treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lux, Michael P., Schneeweiss, Andreas, Hartkopf, Andreas D., Müller, Volkmar, Janni, Wolfgang, Belleville, Erik, Stickeler, Elmar, Thill, Marc, Fasching, Peter A., Kolberg, Hans-Christian, Untch, Michael, Harbeck, Nadia, Wöckel, Achim, Thomssen, Christoph, Schulmeyer, Carla E., Welslau, Manfred, Overkamp, Friedrich, Schütz, Florian, Lüftner, Diana, Ditsch, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046519/
https://www.ncbi.nlm.nih.gov/pubmed/33867564
http://dx.doi.org/10.1055/a-1397-7170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046519/
https://www.ncbi.nlm.nih.gov/pubmed/33867564
http://dx.doi.org/10.1055/a-1397-7170

Ejemplares similares